Drug Shortage Report for CUVITRU
Report ID | 82602 |
Drug Identification Number | 02461692 |
Brand name | CUVITRU |
Common or Proper name | Immune globulin Subcutaneous 20% |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IMMUNOGLOBULIN |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 1g, 2g,4g and 8g |
ATC code | J06BA |
ATC description | IMMUNOGLOBULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-04-09 |
Actual start date | 2019-05-09 |
Estimated end date | 2019-09-30 |
Actual end date | 2019-08-23 |
Shortage status | Resolved |
Updated date | 2019-08-24 |
Company comments | Shortage resolved on 2019-08-23 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-08-24 | English | Compare |
v7 | 2019-08-23 | French | Compare |
v6 | 2019-08-23 | English | Compare |
v5 | 2019-05-10 | English | Compare |
v4 | 2019-05-08 | French | Compare |
v3 | 2019-05-08 | English | Compare |
v2 | 2019-04-29 | French | Compare |
v1 | 2019-04-29 | English | Compare |
Showing 1 to 8 of 8